Clinical Trial Update: An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence. [Phase 2]

View source ↗

Summary

This entry reports the completion of an 8-week Phase 2 study evaluating the efficacy, tolerability, and safety of SS-RBX for stress urinary incontinence. The tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence

Drugs mentioned

• SS-RBX

Snippet

Sponsor: Pfizer | Conditions: Urinary Incontinence, Stress | Phase 2 | Status: COMPLETED